Stoke Therapeutics Stock Price on December 9, 2024
| STOK Stock | USD 11.32 0.29 2.50% |
Below is the normalized historical share price chart for Stoke Therapeutics extending back to June 19, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Stoke Therapeutics stands at 11.32, as last reported on the 24th of December, with the highest price reaching 11.33 and the lowest price hitting 11.32 during the day.
If you're considering investing in Stoke Stock, it is important to understand the factors that can impact its price. Stoke Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0315, which indicates the firm had a -0.0315% return per unit of risk over the last 3 months. Stoke Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Stoke Therapeutics' Coefficient Of Variation of (1,976), variance of 13.77, and Risk Adjusted Performance of (0.03) to confirm the risk estimate we provide.
At this time, Stoke Therapeutics' Total Stockholder Equity is quite stable compared to the past year. Stock Based Compensation is expected to rise to about 26.5 M this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 213.7 M. . At this time, Stoke Therapeutics' Price Fair Value is quite stable compared to the past year. Stoke Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of June 2019 | 200 Day MA 12.9609 | 50 Day MA 12.48 | Beta 0.948 |
Stoke |
Sharpe Ratio = -0.0315
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | STOK |
Estimated Market Risk
| 3.74 actual daily | 33 67% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Stoke Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stoke Therapeutics by adding Stoke Therapeutics to a well-diversified portfolio.
Price Book 2.6493 | Enterprise Value Ebitda (3.62) | Price Sales 36.7286 | Shares Float 37.3 M | Wall Street Target Price 22.5 |
Stoke Therapeutics Main Headline on 9th of December 2024
Disposition of 6786 shares by Kaye Edward M. Md of Stoke The... by MacroaxisInsider
Filed transaction by Stoke Therapeutics Director, Officer: Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Stoke Therapeutics Valuation on December 9, 2024
It is possible to determine the worth of Stoke Therapeutics on a given historical date. On December 9, 2024 Stoke was worth 13.02 at the beginning of the trading date compared to the closed value of 13.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Stoke Therapeutics stock. Still, in general, we apply an absolute valuation method to find Stoke Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Stoke Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Stoke Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 12.57 | 13.45 | 12.57 | 13.27 | 930,468 | |
12/09/2024 | 13.02 | 14.30 | 12.99 | 13.76 | 832,695 |
| 13.89 | 14.39 | 13.04 | 13.26 | 1,053,661 |
| Backtest Stoke Therapeutics | | | Stoke Therapeutics History | | | Stoke Therapeutics Valuation | Previous | Next |
Stoke Therapeutics Trading Date Momentum on December 9, 2024
| On December 10 2024 Stoke Therapeutics was traded for 13.26 at the closing time. The top price for the day was 14.39 and the lowest listed price was 13.04 . The trading volume for the day was 1.1 M. The trading history from December 10, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 3.63% . The trading price change against the current closing price is 18.53% . |
Stoke Therapeutics Fundamentals Correlations and Trends
By evaluating Stoke Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Stoke Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Stoke financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Stoke Therapeutics Stock history
Stoke Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Stoke is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Stoke Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Stoke Therapeutics stock prices may prove useful in developing a viable investing in Stoke Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 44 M | 32.6 M | |
| Net Loss | -91 M | -86.4 M |
Stoke Therapeutics Quarterly Net Working Capital |
|
Stoke Therapeutics Stock Technical Analysis
Stoke Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Stoke Therapeutics Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Stoke Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Stoke Therapeutics December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Stoke Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Stoke Therapeutics shares will generate the highest return on investment. By undertsting and applying Stoke Therapeutics stock market strength indicators, traders can identify Stoke Therapeutics entry and exit signals to maximize returns
Stoke Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Stoke Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Stoke Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Stoke to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.31) | |||
| Treynor Ratio | (0.1) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.08) | Revenue Per Share 0.328 | Quarterly Revenue Growth 0.479 | Return On Assets (0.28) | Return On Equity (0.52) |
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.